BIOGEN INC. - COMMON STOCK

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

17 4月 2024 08:50:10 条件 NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

16 4月 2024 08:45:06 条件 NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

15 4月 2024 08:45:35 条件 NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

12 4月 2024 11:00:50 条件 NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

10 4月 2024 08:45:08 条件 NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

05 4月 2024 08:45:10 条件 NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

04 4月 2024 08:53:33 条件 NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

03 4月 2024 08:55:31 条件 NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

02 4月 2024 08:45:41 条件 NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

01 4月 2024 09:34:07 条件 NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

26 3月 2024 08:50:02 条件 NetDania Notify

New Biomarker Data Add Further Evidence Supporting the Potential Benefit of SPINRAZA® (nusinersen) in Infants and Toddlers with Unmet Clinical Needs after Gene Therapy

06 3月 2024 06:30:51 条件 Nasdaq GlobeNewswire

Biogen Highlights New Data at the International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD™) 2024 Annual Meeting

04 3月 2024 15:15:57 条件 Nasdaq GlobeNewswire

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

01 3月 2024 08:47:17 条件 NetDania Notify

Biogen’s QALSODY® (tofersen), the First Therapy to Treat Rare, Genetic Form of ALS, Received Positive Opinion from CHMP

23 2月 2024 06:00:26 条件 Nasdaq GlobeNewswire

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

20 2月 2024 08:45:15 条件 NetDania Notify

Biogen Received European Commission Approval for SKYCLARYS® (omaveloxolone), the First Therapy to Treat Friedreich’s Ataxia

12 2月 2024 15:06:00 条件 Nasdaq GlobeNewswire

Biogen to Realign Resources for Alzheimer's Disease Franchise

31 1月 2024 06:30:00 条件 Nasdaq GlobeNewswire

Centralized Marketing Authorizations of Generic Versions of TECFIDERA® are Revoked by the European Commission

19 12月 2023 06:30:21 条件 Nasdaq GlobeNewswire

CHMP Issues Positive Opinion for Biogen’s SKYCLARYS® (omaveloxolone), the First Therapy to Treat Friedreich’s Ataxia, a Rare Neurodegenerative Disease

15 12月 2023 08:05:25 条件 Nasdaq GlobeNewswire